Parameter | Base case | SE | Distribution | Reference |
---|---|---|---|---|
RR reduction (%) | Â | Â | Â | Â |
 Diabetes - men | 2.60 | 0.003 | lognormal | [30] |
 Diabetes - women | 2.20 | 0.002 | lognormal | [30] |
 CHD - men | 0.94 | 0.001 | lognormal | [31] |
 CHD - women | 1.14 | 0.001 | lognormal | [31] |
 Stroke - men | 1.20 | 0.001 | lognormal | [32] |
 Stroke - women | 1.70 | 0.002 | lognormal | [33] |
 Colon cancer - men | 1.04 | 0.001 | lognormal | [34] |
 Colon cancer - women | 0.40 | 0.001 | lognormal | [34] |
Cost/year data input (€) 1 |  |  |  |  |
 Diabetes | 3,312 | 331 | gamma | [35] |
 CHD first year | 4,386 | 439 | gamma | |
 CHD subsequent years | 1,183 | 118 | gamma | |
 Stroke first year | 13,319 | 1,332 | gamma | [36] |
 Stroke subsequent years | 4,756 | 476 | gamma | [36] |
 Colon cancer | 9,575 | 958 | gamma | [36] |
 Intervention cost2 | 35 | 3.50 | gamma | [15] |
 Intervention cost3 | 21 | 2.13 | gamma | [15] |
Utilities | Â | Â | Â | Â |
 At risk | 0.71 | 0.04 | beta | [40] |
 Diabetes | 0.63 | 0.06 | beta | [17] |
 CHD 1 | 0.47 | 0.05 | beta | [17] |
 CHD 1+ | 0.56 | 0.06 | beta | [17] |
 Stroke 1 | 0.50 | 0.05 | beta | [17] |
 Stroke 1+ | 0.50 | 0.05 | beta | [17] |
 Colon cancer 1 | 0.64 | 0.06 | beta | [17] |
 Colon cancer 1+ | 0.64 | 0.06 | beta | [17] |
 Dead | 0 |  |  |  |